Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,437.00
Bid: 1,437.00
Ask: 1,438.00
Change: 14.00 (0.98%)
Spread: 1.00 (0.07%)
Open: 1,436.00
High: 1,438.00
Low: 1,436.00
Prev. Close: 1,423.00
SMSN Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results

14 Mar 2014 09:57

RNS Number : 3353C
Samsung Electronics Co. Ld
14 March 2014
 

The Results of the 45th Annual GeneralMeeting of Shareholders

The following are results of the 45th annual general meeting of shareholders that was held on March 14, 2014.

 

1. Agenda Item No.1: approved

 - Approval of Balance Sheet, Income Statement, and Statement of Appropriation of

Retained Earnings (Draft) for the 45th Fiscal Year (from Jan 1, 2013 to Dec 31, 2013)

• Total assets (Consolidated): KRW 214,075,018 million

Total liabilities (Consolidated): KRW 64,059,008 million

• Capital stock (Consolidated): KRW 897,514 million

Total shareholders' equity (Consolidated): KRW 150,016,010 million

Sales (Consolidated): KRW 228,692,667 million

Operating profit (Consolidated): KRW 36,785,013 million

Net income (Consolidated): KRW 30,474,764 million

• Earnings per share (Consolidated): KRW 197,841

- Cash Dividends:

• Year-end dividend per share: KRW 13,800 (common), KRW 13,850 (preferred)

• Interim dividend per share: KRW 500 (common), KRW 500 (preferred)

• Total payout: KRW 2,156,969 million

• Dividend yield (interim + year-end dividends): 1.0% (common share),

1.4% (preferred share)

2. Agenda Item No. 2: approved

- Approval of the limit on the remuneration for the Directors

- Proposed remuneration limit for the 46th fiscal year: KRW 48 billion

- Remuneration limit approved for the 45th fiscal year: KRW 38 billion

- Number of Directors: 9 (including 5 Independent Directors)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGJIMLTMBABMTI
Date   Source Headline
16th Mar 20229:10 amRNSTransaction with Affiliate Company
16th Mar 20229:08 amRNSAppointment of New Chief Executive Officer
16th Mar 20229:06 amRNSResults of the 53rd Annual General Meeting
17th Feb 202210:18 amRNSReference Material for 2022 AGM
17th Feb 20228:40 amRNS2021 Separate Financial Statements
17th Feb 20228:30 amRNS2021 Consolidated Financial Statements
15th Feb 202211:35 amRNSReference Material for 2022 AGM
15th Feb 202211:24 amRNSTransaction with Affiliate Company
15th Feb 202211:21 amRNSAppointment of New Chief Executive Officer
15th Feb 202211:16 amRNSCharitable Contribution
27th Jan 20227:05 amRNSYear-End Dividend for FY2021
27th Jan 20227:00 amRNS2021 4Q Earnings Release
7th Jan 20227:00 amRNSNotice of 4Q 2021 Earnings Release Schedule
7th Jan 20227:00 amRNS4Q 2021 Pre-Earnings Guidance
1st Dec 202110:03 amRNSCharitable Contributions
30th Nov 202112:52 pmRNS2021 3Q Interim Business Report
30th Nov 202111:15 amRNSTransactions with Affiliated Companies
24th Nov 20218:11 amRNSInvestment in Fabrication Plant
10th Nov 20217:55 amRNSAnnouncement of Investor Relations Event
28th Oct 20218:22 amRNSCharitable Contribution
28th Oct 20218:18 amRNSTransaction with Affiliate Company
28th Oct 20218:04 amRNSTransaction with Affiliate Company
28th Oct 20218:03 amRNSQuarterly Dividend for Third Quarter 2021
28th Oct 20217:59 amRNS2021 3Q Earnings Release
8th Oct 20218:05 amRNSNotice of 3Q 2021 Earnings Release Schedule
8th Oct 20218:04 amRNS3Q 2021 Pre-Earnings Guidance
31st Aug 202110:39 amRNS2021 Half-year Business Report
29th Jul 20218:12 amRNSRenewal of Property & Casualty Insurance Policy
29th Jul 20218:07 amRNSQuarterly Dividend for Second Quarter 2021
29th Jul 20218:06 amRNS2021 2Q Earnings Release
7th Jul 20218:25 amRNSNotice of 2Q 2021 Earnings Release Schedule
7th Jul 20218:17 amRNS2Q 2021 Pre-Earnings Guidance
6th Jul 202110:04 amRNSSustainability Report 2021
1st Jun 20217:00 amRNS2021 1Q Interim Report
1st Jun 20217:00 amRNSCorporate Governance Report FY2020
20th May 20219:20 amRNS2020 Separate Financial Statements
12th May 202110:23 amRNS2020 Business Report
30th Apr 202110:28 amRNS2020 Business Report
30th Apr 202110:13 amRNSChange of the Major Shareholder
29th Apr 202110:41 amRNSCharitable Contribution
29th Apr 202110:38 amRNSCharitable Contribution
29th Apr 202110:34 amRNSCharitable Contribution
29th Apr 202110:33 amRNSTransaction with Affiliate Company
29th Apr 202110:26 amRNSQuarterly Dividend for First Quarter 2021
29th Apr 202110:20 amRNS2021 1Q Earnings Release
7th Apr 20219:12 amRNSNotice of 1Q 2021 Earnings Release Schedule
7th Apr 20219:07 amRNS1Q 2021 Pre-Earnings Guidance
17th Mar 20218:39 amRNSTransaction with Affiliate Company
17th Mar 20218:34 amRNSResults of the 52nd Annual General Meeting
18th Feb 20217:34 amRNS2020 Consolidated Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.